Charles Schwab
LJPC

Charles Schwab’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Charles Schwab’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-181,934
Closed -$772K – 3648
2021
Q1 		$772K Sell
181,934
-7,851
-4% -$43.3K ﹤0.01% 2939
2020
Q4 		$737K Hold
189,785
– – ﹤0.01% 2869
2020
Q3 		$765K Sell
189,785
-88,369
-32% -$366K ﹤0.01% 2743
2020
Q2 		$1.19M Buy
278,154
+143,700
+107% +$875K ﹤0.01% 2576
2020
Q1 		$565K Buy
134,454
+15,666
+13% +$98.9K ﹤0.01% 2672
2019
Q4 		$467K Sell
118,788
-10,577
-8% -$62.5K ﹤0.01% 2843
2019
Q3 		$1.14M Buy
129,365
+2,667
+2% +$25.2K ﹤0.01% 2532
2019
Q2 		$1.17M Buy
126,698
+26,194
+26% +$197K ﹤0.01% 2522
2019
Q1 		$647K Sell
100,504
-14,305
-12% -$93.2K ﹤0.01% 2672
2018
Q4 		$1.08M Buy
114,809
+8,229
+8% +$124K ﹤0.01% 2521
2018
Q3 		$2.15M Sell
106,580
-3,000
-3% -$78.4K ﹤0.01% 2408
2018
Q2 		$3.2M Buy
109,580
+23,150
+27% +$715K ﹤0.01% 2209
2018
Q1 		$2.57M Buy
86,430
+11,132
+15% +$359K ﹤0.01% 2234
2017
Q4 		$2.42M Buy
75,298
+10,639
+16% +$348K ﹤0.01% 2243
2017
Q3 		$2.25M Buy
64,659
+36,580
+130% +$1.18M ﹤0.01% 2250
2017
Q2 		$836K Buy
28,079
+6,500
+30% +$186K ﹤0.01% 2522
2017
Q1 		$645K Hold
21,579
– – ﹤0.01% 2560
2016
Q4 		$379K Hold
21,579
– – ﹤0.01% 2757
2016
Q3 		$514K Hold
21,579
– – ﹤0.01% 2605
2016
Q2 		$346K Hold
21,579
– – ﹤0.01% 2733
2016
Q1 		$452K Hold
21,579
– – ﹤0.01% 2617
2015
Q4 		$583K Buy
21,579
+5,000
+30% +$136K ﹤0.01% 2584
2015
Q3 		$461K Hold
16,579
– – ﹤0.01% 2657
2015
Q2 		$407K Buy
+16,579
New +$342K ﹤0.01% 2757

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab's LJPC Position: Q2 2021 in Review

Charles Schwab sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 181,934 shares — an estimated $772K sold.

Charles Schwab first reported a position in LJPC in Q2 2015 and held it in 24 quarters. The position peaked at $3.2M in Q2 2018. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Charles Schwab reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Charles Schwab sold 181,934 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $772K.
  • Charles Schwab first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 24 quarters.
  • Charles Schwab's La Jolla Pharmaceutical Company position peaked at $3.2M in Q2 2018.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.